(Q38030648)

27 August 2017

title

Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future (English)

1 reference

27 August 2017

1 reference

C Boyd

1

1 reference

27 August 2017

D P Boyle

series ordinal

2

1 reference

27 August 2017

publication date

29 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

23

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

286-294

1 reference

The Alder Hey affair: implications for pathology practice

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

The end of surgical pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

The continuing role of morphology in the molecular age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Role of ancillary studies in fine-needle aspiration from selected tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

HER-2/neu gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: direct comparison with companion tissue sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Molecular diagnostic cytopathology: definitions, scope and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Molecular pathology of sarcomas: concepts and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Diagnosis and subclassification of lymphomas and non-neoplastic lesions involving mediastinal lymph nodes using endobronchial ultrasound-guided transbronchial needle aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Evaluation of EGFR mutation status in cytology specimens: an institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Role of BRAF in thyroid oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Intraoperative assessment of sentinel lymph nodes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Observational and cost analysis of the implementation of breast cancer sentinel node intraoperative molecular diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

TP53 mutation and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Molecular pathology in contemporary diagnostic pathology laboratory: an opinion for the active role of surgical pathologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

Fine-needle aspiration as an alternative method for frozen tissue banking of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2303.2012.01004.X

10.1111/J.1365-2303.2012.01004.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference